Default: Diabetes Therapy

ISSN: 1869-6953

Journal Home

Journal Guideline

Diabetes Therapy Q2 Unclaimed

Springer Publishing Company United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Diabetes Therapy is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism and Internal Medicine with an H index of 52. It is an CC BY-NC Journal with a Double blind peer review review system, and It has a price of 3080 €. The scope of the journal is focused on diabetes, obesity, metabolic syndromes, type 1 diabetes, type 2 diabetes. It has an SJR impact factor of 0,938 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,938.

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

3080 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Diabetes Therapy

0,938

SJR Impact factor

52

H Index

146

Total Docs (Last Year)

582

Total Docs (3 years)

5704

Total Refs

1829

Total Cites (3 years)

533

Citable Docs (3 years)

3.05

Cites/Doc (2 years)

39.07

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


Diabetes Obesity Metabolic syndromes Type 1 diabetes Type 2 diabetes



Best articles by citations

Efficacy of Insulin Pump Therapy on Diabetes Treatment Satisfaction and Glycemic Control Among Patients with Type 1 Diabetes Mellitus in Saudi Arabia: A Prospective Study

View more

Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes

View more

Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis

View more

Dialing Torque Preferences of People with Diabetes When Using Insulin Pens: A Pilot Study

View more

Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment

View more

Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study

View more

Association Between Maternal Glucose/Lipid Metabolism Parameters and Abnormal Newborn Birth Weight in Gestational Diabetes Complicated by Preeclampsia: A Retrospective Analysis of 248 Cases

View more

Evaluation of Glycaemic Control, Glucose Variability and Hypoglycaemia on Long-Term Continuous Subcutaneous Infusion vs. Multiple Daily Injections: Observational Study in Pregnancies With Pre-Existing Type 1 Diabetes

View more

The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Renal Outcomes in Type 2 Diabetes

View more

No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects

View more

Letter from the Editor

View more

Changing Patients' Treatment Preferences and Values with a Decision Aid for Type 2 Diabetes Mellitus: Results from the Treatment Arm of a Randomized Controlled Trial

View more
SHOW MORE ARTICLES

Methodological Tools for Exploring Novel Biopharmaceutical Approaches to the Metabolic Syndrome and Related Disorders

View more

Cardiac Versus Non-Cardiac Related Mortality Following Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis

View more

Development and Validation of a New Diabetes Risk Score in Guyana

View more

SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c - Translating Evidence into Practice

View more

Towards a Physiological Prandial Insulin Profile: Enhancement of Subcutaneously Injected Prandial Insulin Using Local Warming Devices

View more

Safety and Efficacy of Empagliflozin as Add-On Therapy to GLP-1 Receptor Agonist (Liraglutide) in Japanese Patients with Type 2 Diabetes Mellitus: A Randomised, Double-Blind, Parallel-Group Phase 4 Study

View more

A Review of the Safety and Adverse Event Profile of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide

View more

Diabetes Distress or Major Depressive Disorder? A Practical Approach to Diagnosing and Treating Psychological Comorbidities of Diabetes

View more

EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China

View more

Accuracy Evaluation of CONTOUR®PLUS Compared With Four Blood Glucose Monitoring Systems

View more

Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme

View more

Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials

View more

FAQS